Other At-Risk Groups GLP-1 medications are generally not suitable for individuals with severe gastrointestinal disorders like gastroparesis, those with type 1 diabetes (as these drugs are approved only for type 2 diabetes and obesity), and people with a history of suicidal thoughts, active eating disorders, or heavy alcohol use
We've seen a significant, sometimes dramatic shift in how people approach weight loss, moving toward powerful medical tools like Semaglutide and Tirzepatide
We ensure that we manage all prior authorization paperwork for weight loss medications, taking the stress out of the process from verification to medication delivery
However, the rapid scaling of production in India also raises questions around supply chain capacity, quality consistency, and regulatory compliance
So, can you skip a week of Wegovy